Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia
Status:
COMPLETED
Trial end date:
2023-08-16
Target enrollment:
Participant gender:
Summary
To assess the efficacy of both first-line antimalarial medications used for the treatment of uncomplicated Plasmodium falciparum malaria infections in two geographic regions in Liberia.
Phase:
PHASE4
Details
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborator:
Ministry of Health, Liberia
Treatments:
Amodiaquine amodiaquine, artesunate drug combination Artemether, Lumefantrine Drug Combination